Best-in-Class handheld diagnostic platform set to disrupt a ~$40B market with highly accurate testing at industry-leading 5-minute turnaround time
Proprietary Electrochemical and AntiSense Oligonucleotide (ASO) based pathogen detection platform offers best-in-class accuracy and sensitivity with breakthrough turnaround time of 5-minutes
POC molecular application addresses key market needs and overcomes competitor deficiencies
Multiple peer-reviewed publications and national organization accolades provide 3rd party validation of foundational technology
AntiSense technology enables expansive menu potential and opportunities to expand target populations, de-risked technology with significant global partners
Multiplexing platform detects multiple infectious diseases simultaneously
Market leading 5-minute molecular assay time to result
Enables utilization in high traffic venues
Multiplexing compatible with wide range of pathogens (e.g. Women’s Health, Respiratory Disease, STDs)
Portable, handheld, easy to use
Enables use in urgent care, pharmacy, physician offices as well as hospitals and nursing homes
